References
- Sutton, E. L. Drug Des. Dev. Ther. 2015, 9, 6035–6042. DOI: https://doi.org/10.2147/DDDT.S73224.
- Minehira, D.; Takahara, S.; Adachi, I.; Toyooka, N. Tetrahedron Lett. 2014, 55, 5778–5780. DOI: https://doi.org/10.1016/j.tetlet.2014.08.086.
- Chen, Y.; Zhou, Y.; Li, J.; Sun, J.; Zhang, G. Chin. Chem. Lett. 2015, 26, 103–107. DOI: https://doi.org/10.1016/j.cclet.2014.09.020.
- Strotman, N. A.; Baxter, C. A.; Brands, K. M. J.; Cleator, E.; Krska, S. W.; Reamer, R. A.; Wallace, D. J.; Wright, T. J. J. Am. Chem. Soc. 2011, 133, 8362–8371. DOI: https://doi.org/10.1021/ja202358f.
- Mangion, I. K.; Sherry, B. D.; Yin, J.; Fleitz, F. J. Org. Lett. 2012, 14, 3458–3461. DOI: https://doi.org/10.1021/ol3014123.
- Cox, C. D.; Breslin, M. J.; Whitman, D. B.; Schreier, J. D.; McGaughey, G. B.; Bogusky, M. J.; Roecker, A. J.; Mercer, S. P.; Bednar, R. A.; Lemaire, W.; et al. J. Med. Chem. 2010, 53, 5320–5332. DOI: https://doi.org/10.1021/jm100541c.
- Baxter, C. A.; Cleator, E.; Brands, K. M. J.; Edwards, J. S.; Reamer, R. A.; Sheen, F. J.; Stewart, G. W.; Strotman, N. A.; Wallace, D. J. Org. Process Res. Dev. 2011, 15, 367–375. DOI: https://doi.org/10.1021/op1002853.
- Iqbal, J.; Dahannukar, V. H.; Oruganti, S.; Kandagatla, B. Process for the preparation of suvorexant and intermediates useful in the synthesis of suvorexant. US20160168138, 2016.
- Kang, J. P.; Pan, Y.; Chen, W.; Su, M. J.; Fang, S. M.; Tao, Y. Method for preparing important suvorexant intermediate. CN106632121, 2017.
- Ji, Y.,B.; Li, C. Z.; Peng, C.; Jin, X. Q.; Li, B. N. Chin. J. Pharm. 2017, 48, 825–832. DOI: https://doi.org/10.16522/j.cnki.cjph.2017.06.007.
- Lee, M.; Rucil, T.; Hesek, D.; Oliver, A. G.; Fisher, J. F.; Mobashery, S. J. Org. Chem. 2015, 80, 7757–7763. DOI: https://doi.org/10.1021/acs.joc.5b01044.